Oracle Fusion Middleware component with unauthenticated remote takeover risk; widespread enterprise use and full system compromise potential warrants org-wide notice.
CVE-2026-60958
Unauthenticated remote takeover of Oracle WebCenter Enterprise Capture (CVSS 9.8)
Is CVE-2026-60958 being exploited?
Not confirmed. CVE-2026-60958 does not appear in CISA's Known Exploited Vulnerabilities catalog, which records only exploitation that has been observed and reported publicly. That is evidence of absence of a report, not evidence the flaw is unattacked. EPSS currently estimates a 0.48% probability of exploitation in the next 30 days.
How severe is CVE-2026-60958?
CVE-2026-60958 is rated Critical with a CVSS score of 9.8. Severity describes how bad exploitation would be, not how likely it is: pair it with exploitation evidence before deciding what to patch first.
Is there a patch for CVE-2026-60958?
Yes. A fix has been recorded for CVE-2026-60958. The vendor advisory is the authority on the exact fixed version — apply it from there rather than from a summary.
What does CVE-2026-60958 affect?
CVE-2026-60958 affects Oracle WebCenter Enterprise Capture 12.2.1.4.0, Oracle WebCenter Enterprise Capture 14.1.2.0.0, Oracle Fusion Middleware (Client Bundle). Confirm the exact affected versions against the vendor advisory before deciding you are exposed.
What should I do about CVE-2026-60958?
Apply vendor patch immediately; if unavailable, block HTTP access, isolate instances, and monitor logs.
Exploitation status reflects CISA's KEV catalog as we last synced it. Check the catalog directly.
Unauthenticated remote full takeover via HTTP of Oracle WebCenter Enterprise Capture; complete C/I/A loss and service takeover.
Immediate action required
- affected12.2.1.4.0
- affected14.1.2.0.0
As published in the CVE Program record. A version outside these ranges is not a statement that it is unaffected — vendors sometimes understate a range, and distribution-backported builds carry upstream numbers that do not reflect what was patched into them.